Solasonine, A Natural Glycoalkaloid Compound, Inhibits Gli-Mediated Transcriptional Activity
Open Access
Abstract
The major obstacle limiting the efficacy of current Smoothened (Smo) inhibitors is the primary and acquired resistance mainly caused by Smo mutations and Gli amplification. In this context, developing Hh inhibitors targeting Gli, the final effector of this signaling pathway, may combat the resistance. In this study we found that solasonine, a natural glycoalkaloid compound, significantly inhibited the hedgehog (Hh) pathway activity. Meanwhile, solasonine may obviously inhibit the alkaline phosphatase (ALP) activity in C3H10T1/2 cells, concomitantly with reductions of the mRNA expression of Gli1 and Ptch1. However, we found that solasonine exhibited no effect on the transcriptional factors activities provoked by TNF-α and PGE2, thus suggesting its selectivity against Hh pathway activity. Furthermore, we identified that solasonine inhibited the Hh pathway activity by acting on its transcriptional factor Gli using a series of complementary data. We also observed that solasonine obviously inhibited the Gli-luciferase activity provoked by ectopic expression of Smo mutants which may cause the resistance to the current Smo inhibitors. Our study suggests that solasonine may significantly inhibit the Hh pathway activity by acting on Gli, therefore indicating the possibility to use solasonine as a lead compound to develop anticancer drugs for combating the resistance of current Smo inhibitors.Keywords
This publication has 28 references indexed in Scilit:
- Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathwayJournal of Clinical Investigation, 2011
- Mechanisms of Hedgehog pathway activation in cancer and implications for therapyTrends in Pharmacological Sciences, 2009
- Hedgehog: functions and mechanismsGenes & Development, 2008
- Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonistsProceedings of the National Academy of Sciences, 2007
- Shh Pathway Activity Is Down-Regulated in Cultured Medulloblastoma Cells: Implications for Preclinical StudiesCancer Research, 2006
- Prostaglandin E2 Stimulates the β-Catenin/T Cell Factor-dependent Transcription in Colon CancerJournal of Biological Chemistry, 2005
- Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1+/−p53−/− miceCancer Cell, 2004
- Induction of Osteogenic Differentiation by Hedgehog ProteinsBiochemical and Biophysical Research Communications, 1997
- Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3Hl0T1/2 and 3T3 CellsGrowth Factors, 1993
- Solanum alkaloids as inhibitors of enzymatic conversion of dihydrolanosterol into cholesterol.Chemical and Pharmaceutical Bulletin, 1987